Astellas Partners with Sangamo for $20M to Revolutionize Neurological Gene Therapy Astellas is taking a significant step forward in its mission to enhance its neurological gene therapy capabilities by paying Sangamo Therapeutics $20 million upfront in a new agreement. This partnersh...

www.linkedin.com/pulse/astell...

Astellas Partners with Sangamo for $20M to Revolutionize Neurological Gene Therapy

kstrategyand.com/pharma-news

#Astellas #SangamoTherapeutics #GeneTherapy #STACBBB #NeurologicalDiseases #BloodBrainBarrier #PharmaPartnership #Humanteconomy #Humantec #KStrategyand